Bisphosphonates significantly increase the activity of doxorubicin or vincristine against canine malignant histiocytosis cells
Authors:
Open Access
- 18 May 2011
- journal article
- Published by Wiley in Veterinary and Comparative Oncology
- Vol. 10 (1) , 44-56
Abstract
Canine malignant histiocytosis (MH) is an aggressive neoplasm of macrophages and dendritic cells. It carries a poor prognosis because of the development of widespread metastasis and poor sensitivity to chemotherapy. Thus, there is a large need for new treatments for MH. We hypothesized that bisphosphonates might be useful to increase the effectiveness of cytotoxic chemotherapy against MH. To address this question, we conductedin vitroscreening studies using MH cell lines and a panel of 6 chemotherapy and 5 bisphosphonate drugs. The combination of clodronate with vincristine was found to elicit synergistic killing which was associated with a significant increase in cell cycle arrest. Second, zoledronate combined with doxorubicin also significantly increased cell killing. Zoledronate significantly increased the uptake of doxorubicin by MH cells. On the basis of these findings, we conclude that certain bisphosphonate drugs may increase the overall effectiveness of chemotherapy for MH in dogs.Keywords
This publication has 66 references indexed in Scilit:
- The histone deacetylase inhibitor valproic acid sensitizes human and canine osteosarcoma to doxorubicinCancer Chemotherapy and Pharmacology, 2010
- Macrophages are an abundant component of myeloma microenvironment and protect myeloma cells from chemotherapy drug–induced apoptosisBlood, 2009
- Zoledronic acid in treatment of bone lesions by Langerhans cell histiocytosisJournal of Bone and Mineral Metabolism, 2008
- CCNU for the Treatment of Dogs with Histiocytic SarcomaJournal of Veterinary Internal Medicine, 2007
- Evaluation of liposomal clodronate in experimental spontaneous autoimmune hemolytic anemia in dogsExperimental Hematology, 2006
- Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approachBritish Journal of Cancer, 2006
- Histiocytic sarcomas in flat‐coated retrievers: a summary of 37 cases (November 1998–March 2005)Veterinary and Comparative Oncology, 2006
- The effects of liposome-encapsulated and free clodronate on the growth of macrophage-like cellsin vitro: The role of calcium and ironCalcified Tissue International, 1993
- Cytosine‐arabinoside, vincristine, and prednisolone in the treatment of children with disseminated langerhans cell histiocytosis with organ dysfunction: Experience at a single institutionMedical and Pediatric Oncology, 1993
- Pharmacokinetics of Clodronate after Single Intravenous, Intramuscular and Subcutaneous Injections in RatsBasic & Clinical Pharmacology & Toxicology, 1991